Sign up to save your podcasts
Or
Share 261 - Hearing Therapeutics in 2025: Where Are We, and What’s Next?
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
261 - Hearing Therapeutics in 2025: Where Are We, and What’s Next?
Hearing therapeutics are advancing rapidly, but how close are we to real breakthroughs? That was the focus of The State of Hearing Therapeutics, a panel discussion held during the 2025 Hearing Therapeutics Summit on February 4.
Moderated by Brian Taylor, AuD, the panel featured Hugo Peris (Spiral Therapeutics), Tony Ricci, PhD (Stanford University School of Medicine), Jian Zuo, PhD (Ting Therapeutics), Dr. Douglas Hartley (Rinri Therapeutics), and Jonas Dyhrfjeld-Johnsen, PhD (Acousia Therapeutics).
The discussion provided a deep dive into the latest advancements in hearing restoration, including gene therapy, regenerative medicine, and pharmaceutical approaches to treating sensorineural hearing loss.
Panelists explored the current state of clinical research, regulatory pathways, and the challenges of bringing novel hearing therapeutics to market. They also discussed the growing role of precision medicine and targeted drug delivery in shaping the future of hearing healthcare. As scientific breakthroughs continue, collaboration across academia, industry, and clinical practice will be critical in accelerating the development of effective treatments.
Be sure to subscribe to our YouTube channel for the latest episodes each week, and follow This Week in Hearing on LinkedIn and X (formerly Twitter):
View all episodes
By This Week in Hearing
5
11 ratings
Hearing therapeutics are advancing rapidly, but how close are we to real breakthroughs? That was the focus of The State of Hearing Therapeutics, a panel discussion held during the 2025 Hearing Therapeutics Summit on February 4.
Moderated by Brian Taylor, AuD, the panel featured Hugo Peris (Spiral Therapeutics), Tony Ricci, PhD (Stanford University School of Medicine), Jian Zuo, PhD (Ting Therapeutics), Dr. Douglas Hartley (Rinri Therapeutics), and Jonas Dyhrfjeld-Johnsen, PhD (Acousia Therapeutics).
The discussion provided a deep dive into the latest advancements in hearing restoration, including gene therapy, regenerative medicine, and pharmaceutical approaches to treating sensorineural hearing loss.
Panelists explored the current state of clinical research, regulatory pathways, and the challenges of bringing novel hearing therapeutics to market. They also discussed the growing role of precision medicine and targeted drug delivery in shaping the future of hearing healthcare. As scientific breakthroughs continue, collaboration across academia, industry, and clinical practice will be critical in accelerating the development of effective treatments.
Be sure to subscribe to our YouTube channel for the latest episodes each week, and follow This Week in Hearing on LinkedIn and X (formerly Twitter):
More shows like This Week in Hearing
View all
Fresh Air
38,478 Listeners
Pivot
9,503 Listeners
How I Built This with Guy Raz
30,270 Listeners
Pod Save America
87,200 Listeners
The Daily
112,454 Listeners
Pod Save the World
24,686 Listeners
The Diary Of A CEO with Steven Bartlett
8,434 Listeners
Post Reports
5,427 Listeners
Hearing Matters Podcast
20 Listeners
SmartLess
58,247 Listeners
ADHD Women's Wellbeing Podcast
165 Listeners
After Dark: Myths, Misdeeds & the Paranormal
1,043 Listeners